Rate of cardiovascular events up to 8 years after uncomplicated myocarditis: a nationwide cohort study.

IF 3.9 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal: Acute Cardiovascular Care Pub Date : 2024-05-28 DOI:10.1093/ehjacc/zuae021
Andreas Schelldorfer, Claudia Gregoriano, Stephanie Hauser, Tobias A Fuchs, Beat Mueller, Philipp Schuetz, Alexander Kutz
{"title":"Rate of cardiovascular events up to 8 years after uncomplicated myocarditis: a nationwide cohort study.","authors":"Andreas Schelldorfer, Claudia Gregoriano, Stephanie Hauser, Tobias A Fuchs, Beat Mueller, Philipp Schuetz, Alexander Kutz","doi":"10.1093/ehjacc/zuae021","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>While prognosis of acute myocarditis with uncomplicated presentation is perceived as benign, data on long-term outcomes are scarce. We evaluated rates of myocarditis-associated cardiovascular events after a first-time hospitalization with uncomplicated acute myocarditis in patients without known heart disease.</p><p><strong>Methods and results: </strong>In this retrospective nationwide population-based cohort study from 2013 to 2020, hospitalized patients with uncomplicated acute myocarditis but without known heart disease were 1:1 propensity score-matched with surgical controls hospitalized for laparoscopic appendectomy. As assessed in time-to-event analyses, the primary outcome was a composite of rehospitalization for myocarditis, pericardial disease, heart failure and its complications, arrhythmias, implantation of cardiac devices, and heart transplant. After matching, we identified 1439 patients with uncomplicated acute myocarditis (median age of 35 years, 74.0% male) and 1439 surgical controls (median age of 36 years, 74.4% male). Over a median follow-up of 39 months, compared with surgical controls, the hazard ratio for the primary composite outcome was 42.3 [95% confidence interval (CI) 17.4-102.8], corresponding to an incidence rate of 43.7 vs. 0.9 per 1000 patient-years (py) and an incidence rate difference of 42.7 (95% CI 36.7-48.8) per 1000 py.</p><p><strong>Conclusion: </strong>Patients hospitalized with uncomplicated acute myocarditis and no known prior heart disease were associated with substantial risk for cardiovascular events over a follow-up of up to 8 years. This calls for a more efficient therapeutic management of this population of patients.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"401-410"},"PeriodicalIF":3.9000,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11132296/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal: Acute Cardiovascular Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjacc/zuae021","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: While prognosis of acute myocarditis with uncomplicated presentation is perceived as benign, data on long-term outcomes are scarce. We evaluated rates of myocarditis-associated cardiovascular events after a first-time hospitalization with uncomplicated acute myocarditis in patients without known heart disease.

Methods and results: In this retrospective nationwide population-based cohort study from 2013 to 2020, hospitalized patients with uncomplicated acute myocarditis but without known heart disease were 1:1 propensity score-matched with surgical controls hospitalized for laparoscopic appendectomy. As assessed in time-to-event analyses, the primary outcome was a composite of rehospitalization for myocarditis, pericardial disease, heart failure and its complications, arrhythmias, implantation of cardiac devices, and heart transplant. After matching, we identified 1439 patients with uncomplicated acute myocarditis (median age of 35 years, 74.0% male) and 1439 surgical controls (median age of 36 years, 74.4% male). Over a median follow-up of 39 months, compared with surgical controls, the hazard ratio for the primary composite outcome was 42.3 [95% confidence interval (CI) 17.4-102.8], corresponding to an incidence rate of 43.7 vs. 0.9 per 1000 patient-years (py) and an incidence rate difference of 42.7 (95% CI 36.7-48.8) per 1000 py.

Conclusion: Patients hospitalized with uncomplicated acute myocarditis and no known prior heart disease were associated with substantial risk for cardiovascular events over a follow-up of up to 8 years. This calls for a more efficient therapeutic management of this population of patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无并发症心肌炎8年后的心血管事件发生率:全国性队列研究。
背景:虽然无并发症急性心肌炎的预后被认为是良性的,但有关长期预后的数据却很少。我们评估了无已知心脏病患者首次因无并发症急性心肌炎住院后心肌炎相关心血管事件的发生率:在这项2013年至2020年全国范围内的回顾性人群队列研究中,患有无并发症急性心肌炎但无已知心脏病的住院患者与因腹腔镜阑尾切除术住院的外科对照组进行了1:1倾向评分匹配。通过时间到事件分析评估,主要结果是心肌炎、心包疾病、心力衰竭及其并发症、心律失常、植入心脏设备和心脏移植的再住院综合结果:经过配对,我们确定了 1439 名无并发症急性心肌炎患者(中位年龄 35 岁,74.0% 为男性)和 1439 名手术对照组患者(中位年龄 36 岁,74.4% 为男性)。中位随访时间为39个月,与手术对照组相比,主要综合结果的危险比(HR)为42.3(95%置信区间[CI],17.4至102.8),对应的发病率(IR)为每1,000患者年(py)43.7例与每1,000患者年(py)0.9例,发病率差异(IRD)为每1,000患者年(py)42.7例(95%CI,36.7至48.8):结论:因无并发症的急性心肌炎住院且既往无心脏病史的患者,在长达8年的随访过程中极易发生心血管事件。因此需要对这部分患者进行更有效的治疗管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.50
自引率
4.90%
发文量
325
期刊介绍: The European Heart Journal - Acute Cardiovascular Care (EHJ-ACVC) offers a unique integrative approach by combining the expertise of the different sub specialties of cardiology, emergency and intensive care medicine in the management of patients with acute cardiovascular syndromes. Reading through the journal, cardiologists and all other healthcare professionals can access continuous updates that may help them to improve the quality of care and the outcome for patients with acute cardiovascular diseases.
期刊最新文献
Question: Syncope and chest discomfort on flecainide: a diagnostic dilemma. Efficacy and safety of colchicine and spironolactone after myocardial infarction: The CLEAR-SYNERGY trial in perspective. Device-Related Adverse Events and Flow Capacity of Percutaneous Ventricular Assist Devices. The future for cardiogenic shock management - Insights from the leaders of the ESC. Echocardiographic Assessment of Right Ventricular Adaptation and Pulmonary Embolism: A Perfect Couple?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1